A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
Clinical trial NCT00309686 · COMPLETED
Trial details
- NCT number
- NCT00309686
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.